Arthritis and Cholesterol Drugs Well Tolerated in Prostate Cancer Treatment

Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex(r) and Lipitor(r) -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer. Preliminary results from an ongoing Phase II clinical trial will be presented this week during the 2012 Genitourinary Cancers Symposium.

Prostate Cancer Therapies

One in six men in the USA and Canada will require some form of prostate cancer treatment. This is a frightening idea, but countering} it is the information that around 90% of cases of prostate cancer . . .